COMPANY PROFILES 2008 The Research Group of Godsey & Gibb Associates compiled the following information in Godsey & Gibb Associates’ 2008 Company Profiles from Reuters’ Company Profiles. These reports are intended solely for the clients of Godsey & Gibb Associates and its affiliates. This material is for informational purposes only and is not intended to be a recommendation for the purchase or sale of any individual security. GODSEY & GIBB COMPANY PROFILES 2008 TABLE OF CONTENTS AFLAC Inc. (AFL)………………………………………………………………………………………. 1 AGL Resources Inc. (ATG)…………………………………………………………………………… 3 American Electric Power Co. Inc. (AEP)….………………………………………………………… 5 AT&T, Inc (T)…………………………………………………………………………………………… 7 Barrick Gold Corp. (ABX)……………………….……………………………………………………. 9 BB&T Corp. (BBT)………………………………………………………………..…………………… 10 BP, plc (BP)…………………………………………………………………………………….………. 12 Cisco Systems, Inc. (CSCO)……………………………………………………………….………… 13 Cognizant Technology Solutions (CTSH)……………………………………………………….….. 15 CVS Caremark Corp. (CVS)………………………………………………………………………….. 16 Dominion Resources, Inc. (D)………………………………………………….…………………….. 17 Emerson Electric Co. (EMR)………………………………………………………………………….. 19 Express Scripts, Inc. (ESRX)…………………………………………………………………..……… 23 ExxonMobil Corp. (XOM)………………………………………………………………….…………… 24 General Electric Company (GE)………………………………………………………………..……. 26 Gilead Sciences, Inc. (GILD)…………………………………………………………………………. 27 W.W. Grainger, Inc. (GWW)………………………………………………………………………….. 30 Hewlett-Packard Co. (HPQ)………………………………………………………………………….. 32 Integrys Energy Group, Inc. (TEG)………………………………………………………………….. 35 L-3 Communications Holdings, Inc. (LLL)…………………………………………………………… 36 Medtronic, Inc. (MDT)…………………………………………………………………………………. 37 Microchip Technologies, Inc. (MCHP)………………………………………………………………. 39 Microsoft Corp. (MSFT)……………………………………………………………………………….. 40 Northern Trust Corp. (NTRS)………………………………………………………………………… 42 Novartis AG (NVS)……………………………………………………………………………………. 43 Nstar (NST)……………………………………………………………………………………………. 45 Oracle Corp. (ORCL)…………………………………………………………………………………. 46 Pepco Holdings, Inc. (POM)…………………………………………………………………………. 48 PepsiCo, Inc. (PEP)…………………………………………………………………………………… 49 Pfizer, Inc. (PFE) ………………..……………………………………………………………………. 51 Proctor & Gamble Co. (PG)…………………………………………………………………………… 53 Progress Energy, Inc. (PGN)…………………………………………………………………………. 54 SAP AG (SAP)…………………………………………………………………………………………. 55 SCANA Corp. (SCG)………………………………………………………………………………….. 57 Schlumberger Limited (SLB)…………………………………………………………………………. 58 Southern Company (SO)……………………………………………………………………………… 60 The Research Group of Godsey & Gibb Associates compiled the following information in Godsey & Gibb Associates’ 2008 Company Profiles from Reuters’ Company Profiles. These reports are intended solely for the clients of Godsey & Gibb Associates and its affiliates. This material is for informational purposes only and is not intended to be a recommendation for the purchase or sale of any individual security. TABLE OF CONTENTS Stryker Corp. (SYK)……………..……………………………………………………………………. 61 Sysco Corp. (SYY)…………………………………………………………………………………….. 64 Target Corporation (TGT)…………………………………………………………………………….. 65 Teva Pharmaceutical Industries Limited (TEVA)…………………………………………………… 66 Texas Instruments Inc. (TXN)………………………………………………………………………… 68 United Technologies Corp. (UTX)………..……………..…………………………………………… 69 Valero Energy Corp. (VLO)…………………………………………………………………………… 72 Walgreen Company (WAG)………………………………………………………………………….. 74 WGL Holdings, Inc. (WGL)…………………………………………………………………………… 75 Xcel Energy, Inc. (XEL)……………………………………………………………………………….. 76 XTO Energy, Inc. (XTO)………………………………………………………………………………. 77 The Research Group of Godsey & Gibb Associates compiled the following information in Godsey & Gibb Associates’ 2008 Company Profiles from Reuters’ Company Profiles. These reports are intended solely for the clients of Godsey & Gibb Associates and its affiliates. This material is for informational purposes only and is not intended to be a recommendation for the purchase or sale of any individual security. COMPANY PROFILE AFLAC Inc. (AFL) Web Site: http://www.aflac.com/ Aflac Incorporated, incorporated in 1973, is a general business holding company and acts as a management company, overseeing the operations of its subsidiaries by providing management services and making capital available. Its principal business is supplemental health and life insurance, which is marketed and administered through its subsidiary, American Family Life Assurance Company of Columbus (Aflac), which operates in the United States (Aflac U.S.) and as a branch in Japan (Aflac Japan). Most of Aflac's policies are individually underwritten and marketed through independent agents. Aflac Japan sells supplemental insurance products, including cancer life plans, general medical indemnity plans, medical/sickness riders, care plans, living benefit life plans, ordinary life insurance plans and annuities. Aflac U.S. sells supplemental insurance products, including accident/disability plans, cancer expense plans, short-term disability plans, sickness and hospital indemnity plans, hospital intensive care plans, fixed-benefit dental plans, vision care plans, long-term care plans, and life insurance products. During the year ended December 31, 2007, Aflac Japan accounted for 71% of the Company’s total revenues. Aflac’s insurance business consists of two segments: Aflac Japan and Aflac U.S. Aflac Japan, which operates as a branch of Aflac. Insurance Products - Japan Aflac Japan’s stand-alone medical product, EVER, offers a basic level of hospitalization coverage with an affordable premium. The Company’s added to its medical product portfolio in February 2007, with EVER Paid Up, a product that allows policyholders to choose to pay higher premium payments on the front end so they will be payment-free at either age 60 or 65. In August 2007, it introduced Gentle EVER, which helps consumers who may have a health condition that would exclude them from purchasing the other EVER products. The cancer life insurance plans the Company offers in Japan provides a lump-sum benefit upon initial diagnosis of internal cancer and a fixed daily benefit for hospitalization and outpatient services related to cancer, as well as surgical, convalescent and terminal care benefits. In September 2007, it introduced a new product called Cancer Forte. The life products that the Company offers in Japan provides death benefits and cash surrender values. These products are available as stand- alone policies and riders. Some plans have features that allow policyholders to convert a portion of their life insurance to medical, nursing care, or fixed annuity benefits at a predetermined age. The Company also offers traditional fixed-income annuities and care policies. Insurance Products - U.S. The Company designs its U.S. insurance products to provide supplemental coverage for people who already have major medical or primary insurance coverage. Its policies are portable and pay regardless of other insurance. Benefits are paid in cash directly to policyholders, therefore they have the opportunity to use this cash to cover expenses of their choosing. The Company’s health insurance plans are guaranteed-renewable for the lifetime of the policyholder (to age 70 for short-term disability policies). Aflac U.S. offers an accident and disability policy to protect against losses resulting from accidents. The accident portion of the policy includes lump-sum benefits for accidental death, dismemberment and specific injuries as well as fixed benefits for hospital confinement. Optional disability riders are also available. Short-term disability policies provide disability benefits with a variety of elimination and benefit period options. The longest such benefit period offered is two years. The Company’s U.S. cancer plans are designed to provide insurance benefits for medical and non-medical costs that are not covered by major medical insurance. Benefits include a first-occurrence benefit that pays an initial amount when internal cancer is first diagnosed; a fixed amount for each day an insured is hospitalized for cancer treatment; fixed amounts for radiation, chemotherapy and surgery, and a wellness benefit applicable toward certain diagnostic tests. In August 2007, the Company introduced its newest cancer product, Maximum Difference. This cancer indemnity plan incorporates coverage for medical advances in cancer prevention, diagnosis, treatment and the many new ways cancer patients may receive their care. Maximum Difference allows customization of coverage to fit varying needs and budgets. The Company’s hospital indemnity products provide fixed daily benefits for hospitalization due to accident or sickness. Aflac U.S. offers a specified health event policy that gives consumers three benefit and premium levels from which they may select. One of the levels combines the specified health event policy with the Company's intensive care plan. By leveraging administrative efficiencies, consumers can purchase the combined coverage for less than purchasing the policies separately. Source: Page 1 COMPANY PROFILE Aflac U.S. offers term and whole life policies sold through payroll deduction at the worksite and various term and whole life policies on a direct basis. The Life Protector Series product line offers term policies with varying duration options and a new whole life policy with additional benefits, including an increased face value option. It also offers a series of fixed-benefit dental policies, providing various levels of benefits